tolbutamide has been researched along with prednisolone in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (40.74) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (22.22) | 29.6817 |
2010's | 10 (37.04) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ito, S | 1 |
B oyes, BE; Dymock, IW; Leeming, JT; Woolf, IL | 1 |
Hirayama, C | 1 |
Yoshida, T | 1 |
Joubert, SM; Kallie, RN | 1 |
Rastogi, GK; Singhal, KC | 1 |
Boyer, MH | 1 |
BIANUCCI, G; PALADINI, R; VALLECORSI, G | 1 |
SCHWARTZ, W | 1 |
AHUJA, MM | 1 |
FUJINAKA, S; KOBASHI, K; ONOE, K | 1 |
2 review(s) available for tolbutamide and prednisolone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[INSULIN ANTIBODIES].
Topics: Adrenocorticotropic Hormone; Animals; Autoimmune Diseases; Diabetes Mellitus; Diabetic Angiopathies; Female; Guinea Pigs; Hemagglutination; Humans; Hypersensitivity; Insulin Antibodies; Pharmacology; Prednisolone; Pregnancy; Pregnancy in Diabetics; Research; Tolbutamide | 1964 |
25 other study(ies) available for tolbutamide and prednisolone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Thyroid hormones].
Topics: Androgens; Chloroquine; Diethylstilbestrol; Estrogens; Female; Humans; Hydrocortisone; Hydroflumethiazide; Hyperthyroidism; Hypothyroidism; In Vitro Techniques; Male; Prednisolone; Pregnancy; Salicylates; Serum Globulins; Testosterone; Thyroid Function Tests; Thyroxine; Thyroxine-Binding Proteins; Tolbutamide | 1967 |
Active chronic hepatitis in the elderly.
Topics: Age Factors; Aged; Azathioprine; Chronic Disease; Diabetes Mellitus; Female; Hepatitis; Hepatomegaly; Humans; Liver Function Tests; Prednisolone; Tolbutamide | 1974 |
Tryptophan metabolism in liver disease.
Topics: Adult; Aged; Amino Acids; Ammonia; Brain Diseases; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Fasting; Female; Hepatic Encephalopathy; Hepatitis; Humans; Liver Cirrhosis; Liver Function Tests; Male; Methenolone; Middle Aged; Peptic Ulcer; Prednisolone; Syphilis; Tolbutamide; Tryptophan | 1971 |
[Clinical studies on the immunoreactive insulin. II. The immunoreactive insulin (IRI) in normal subjects and patients with diabets mellitus and other endocrinopathy].
Topics: Acromegaly; Adolescent; Adult; Aged; Anemia, Aplastic; Arginine; Child; Child, Preschool; Circadian Rhythm; Diabetes Mellitus; Dwarfism, Pituitary; Endocrine System Diseases; Female; Gastrectomy; Glucose Tolerance Test; Humans; Hyperthyroidism; Infant; Infant, Newborn; Insulin; Male; Mental Disorders; Middle Aged; Prednisolone; Radioimmunoassay; Tolbutamide | 1970 |
Studies in primary hyperuricaemia. II. Glucose tolerance before and after prednisolone sensitization. IV. Tolbutamide response and fasting serum cholesterol and triglycerides.
Topics: Adult; Aged; Cholesterol; Fatty Acids, Nonesterified; Glucose Tolerance Test; Gout; Humans; Middle Aged; Prednisolone; Tolbutamide; Triglycerides; Uric Acid | 1968 |
Young insulin-refractory diabetics.
Topics: Adolescent; Adult; Age Factors; Diabetes Mellitus; Female; Humans; Insulin; Insulin Resistance; Male; Prednisolone; Tolbutamide | 1969 |
Hyperosmolar anacidotic coma in association with glucocorticoid therapy.
Topics: Acidosis; Adult; Aged; Coma; Dehydration; Female; Humans; Hyperglycemia; Male; Middle Aged; Osmosis; Prednisolone; Tolbutamide | 1967 |
[Dynamic effect of tolbutamide on blood sugar and inorganic phosphorus in blood after prednisolone administration].
Topics: Blood Glucose; Humans; Hypoglycemic Agents; Pharmaceutical Preparations; Phosphorus; Prednisolone; Tolbutamide | 1958 |
MEBUTAMATE AND HYDROCHLOROTHIAZIDE IN HYPERTENSION.
Topics: Antihypertensive Agents; Arthritis; Arthritis, Rheumatoid; Blood Pressure Determination; Carbamates; Coronary Disease; Diabetes Mellitus; Digitalis; Geriatrics; Hydrochlorothiazide; Hypertension; Nitroglycerin; Obesity; Parkinsonian Disorders; Prednisolone; Reserpine; Tolbutamide | 1964 |
RENAL GLYCOSURIA. FAILURE TO ESTABLISH EVIDENCE OF 'POTENTIAL' DIABETES BY THE PREDNISOLONE TOLBUTAMIDE TEST.
Topics: Diabetes Mellitus; Diagnosis, Differential; Glucose Tolerance Test; Glycosuria; Glycosuria, Renal; Humans; Hyperthyroidism; India; Kidney Function Tests; Kidney Tubules; Prednisolone; Pregnancy; Tolbutamide | 1964 |